| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 13.185 | 12.378 | 4.725 | 0 | 0 | 0 |
| Total Income - EUR | - | - | - | - | 14.890 | 18.325 | 10.541 | 5.833 | 5.816 | 2.132 |
| Total Expenses - EUR | - | - | - | - | 16.037 | 28.561 | 13.998 | 6.095 | 5.816 | 4.366 |
| Gross Profit/Loss - EUR | - | - | - | - | -1.147 | -10.236 | -3.457 | -262 | 0 | -2.233 |
| Net Profit/Loss - EUR | - | - | - | - | -1.279 | -10.355 | -3.536 | -262 | 0 | -2.233 |
| Employees | - | - | - | - | 2 | 2 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Doctofresh S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 28.290 | 21.806 | 15.508 | 9.722 | 3.877 | 0 |
| Current Assets | - | - | - | - | 7.833 | 647 | 583 | 586 | 585 | 656 |
| Inventories | - | - | - | - | 424 | 514 | 578 | 580 | 578 | 575 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | - | - | - | 7.409 | 133 | 4 | 6 | 6 | 81 |
| Shareholders Funds | - | - | - | - | -1.237 | -11.569 | -14.848 | -15.155 | -15.109 | -17.259 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 10.877 | 13.987 | 17.163 | 17.480 | 17.427 | 17.914 |
| Income in Advance | - | - | - | - | 26.484 | 20.035 | 13.775 | 7.984 | 2.144 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1032 - 1032" | |||||||||
| CAEN Financial Year |
1032
|
|||||||||
Comments - Doctofresh S.r.l.